Skip to content

A Randomized Controlled Study on the Ultrasound-Guided Anterior Inferior Iliac Spine Block Test and Arthroscopic Techniques for the Precise Diagnosis and Treatment of Anterior Inferior Iliac Spine Impingement Syndrome

A Randomized Controlled Study on the Ultrasound-Guided Anterior Inferior Iliac Spine Block Test and Arthroscopic Techniques for the Precise Diagnosis and Treatment of Anterior Inferior Iliac Spine Impingement Syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088989
Enrollment
Unknown
Registered
2024-08-30
Start date
2024-08-30
Completion date
Unknown
Last updated
2024-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior Inferior Iliac Spine Impingement Syndrome

Interventions

ultrasound-guided AIIS injection test positive --AIIS Formed group :Arthroscopic anterior inferior iliac spine decompression
ultrasound-guided AIIS injection test positive --AIIS non-developed Formed group :Do not perform arthroscopic anterior inferior iliac spine decompression
ultrasound-guided AIIS injection test negative --AIIS non-developed Formed group :Do not perform arthroscopic anterior inferior iliac spine decompression

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: (1) Age 18-55; (2) Preoperative X-ray, CT, and MRI clearly diagnose FAI, and are accompanied by type II and type III anterior inferior iliac spine morphology; (3) Physical examination with flexion, adduction, and internal rotation (FADIR) or flexion, abduction, and external rotation (FABER) can reproduce hip joint pain; (4) Pain has persisted for more than 6 months and conservative treatment has been ineffective for 3 months; (5) Able to provide informed and effective consent to participate in the study, and complete the relevant plan and follow-up.

Exclusion criteria

Exclusion criteria: 1. Presence of lower limb neurological symptoms or signs. 2. Diffuse idiopathic skeletal hyperostosis. 3. Hip synovial chondromatosis. 4. Previous surgery on the ipsilateral hip joint or history of contralateral hip joint surgery during follow-up. 5. Preoperative LCEA (Lateral Center-Edge Angle) less than 25°. 6. Moderate to severe osteoarthritis (Tönnis grade = 2). 7. Sacroiliac joint diseases. 8. Patients with severe cardiovascular or neurological diseases. 9. Women who are pregnant or breastfeeding. 10. Inability to attend regular follow-up appointments in the future.

Design outcomes

Primary

MeasureTime frame
modified Harris Hip Score (mHHS);

Secondary

MeasureTime frame
Visual Analog Scale, VAS;Hip Outcome Score - Activities of Daily Living, HOS-ADL;International Hip Outcome Tool-12, iHOT-12; Knee joint muscle strength testing ;Hip joint muscle strength testing ;

Countries

China

Contacts

Public ContactJianquan Wang

Peking University Third Hospital

wjqsportsmed@163.com+86 138 0107 6267

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026